$175 Wellness Injections Fast, effective support with no downtimeperfect for busy schedules or in-between visits
FOXO4-DRI Key Research Facts Full name: FOXO4 D-Retro-Inverso peptide (FOXO4-DRI) Classification: Cell-penetrating senolytic peptide FOXO4/p53 protein-protein interaction inhibitor Design: D-retro-inverso isoform of FOXO4s p53-binding domain reversed sequence with all D-amino acids Binding target: p53 transactivation domain 2 (TAD2) displaces FOXO4 from the FOXO4-p53 complex Mechanism: FOXO4-DRI binds p53 TAD2 p53 nuclear exclusion p53 mitochondrial translocation BAX activation caspase-3 cleavage senescent cell-selective apoptosis Selectivity basis: FOXO4 is upregulated in senescent cells but expressed at low levels in most non-senescent adult cells selectivity is mechanistically conferred D-amino acid advantage: Proteolytic stability resistant to intracellular peptidases that would rapidly degrade equivalent L-amino acid sequences Structural characterisation: NMR structural models of FOXO4-DRI/p53TAD2 complex resolved (Nature Communications, 2025) confirms disordered-to-ordered transition upon binding Research cell types studied: IMR90 fibroblasts, TM3 Leydig cells, endothelial cells, chondrocytes, keloid fibroblasts, HCT116 cancer cells In vitro working concentration: 25 M used in multiple published studies for senescent cell apoptosis induction What Does FOXO4-DRI Do in Research
If had we not brought the lawsuit, I think it would have been one of those situations that they made the rule, nobody fought it, so they just kind of went on down the road and just said, this is the way that it's going to be," says Dan DeNeui, CEO of EVEXIAS Life Sciences & Managing Partner of FarmaKeio Pharmacy Network
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs (in Eng)
Their report showed that the mean overall survival time in patients receiving the peptide cocktail improved compared with the control group [134]
See the full research catalog or jump to another category below
